Golumbeski George
Insider CIK 1586660 · ENTA Director · ABOS Director · CRBP Director · SAGE Director · STTK Director · MURA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ABOS Acumen Pharmaceuticals, In | A Award deriv | 2026-06-03 | 2026-06-05 | 53,250 | — | $0 | 53,250 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award | 2026-06-03 | 2026-06-05 | 35,500 | — | $0 | 35,500 | SEC↗ |
| STTK Shattuck Labs, Inc. | A Award deriv | 2026-05-29 | 2026-06-02 | 81,000 | — | $0 | 81,000 | SEC↗ |
| MURA Mural Oncology plc | D To issuer deriv | 2025-12-05 | 2025-12-05 | 15,334 | — | $0 | 0 | SEC↗ |
| MURA Mural Oncology plc | D To issuer deriv | 2025-12-05 | 2025-12-05 | 8,637 | — | $0 | 0 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award deriv | 2025-11-06 | 2025-11-10 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | D To issuer deriv | 2025-07-31 | 2025-07-31 | 13,593 | — | $0 | 0 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | D To issuer deriv | 2025-07-31 | 2025-07-31 | 21,500 | — | $0 | 0 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | U Tender | 2025-07-31 | 2025-07-31 | 8,000 | — | $0 | 0 | SEC↗ |
| STTK Shattuck Labs, Inc. | A Award deriv | 2025-07-14 | 2025-07-16 | 33,150 | — | $0 | 33,150 | SEC↗ |
| MURA Mural Oncology plc | A Award deriv | 2025-06-11 | 2025-06-13 | 8,637 | — | $0 | 8,637 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2025-06-11 | 2025-06-13 | 21,500 | — | $0 | 21,500 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2025-01-03 | 2025-01-06 | 13,593 | — | $0 | 13,593 | SEC↗ |
| MURA Mural Oncology plc | A Award deriv | 2024-07-30 | 2024-07-31 | 15,334 | — | $0 | 15,334 | SEC↗ |
| STTK Shattuck Labs, Inc. | A Award deriv | 2024-06-21 | 2024-06-21 | 27,700 | — | $0 | 27,700 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2024-06-10 | 2024-06-11 | 12,500 | — | $0 | 12,500 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2024-01-03 | 2024-01-04 | 3,495 | — | $0 | 3,495 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2023-06-15 | 2023-06-16 | 10,000 | — | $0 | 10,000 | SEC↗ |
| STTK Shattuck Labs, Inc. | A Award deriv | 2023-05-26 | 2023-05-31 | 40,258 | — | $0 | 40,258 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2023-01-04 | 2023-01-05 | 2,108 | — | $0 | 2,108 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2022-06-16 | 2022-06-17 | 9,947 | — | $0 | 9,947 | SEC↗ |
| STTK Shattuck Labs, Inc. | A Award deriv | 2022-06-08 | 2022-06-10 | 40,258 | — | $0 | 40,258 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | P Buy | 2022-05-05 | 2022-05-09 | 8,000 | $31.45 | $251.6K | 8,000 | SEC↗ |
| STTK Shattuck Labs, Inc. | P Buy | 2022-04-26 | 2022-04-27 | 28,330 | $3.63 | $102.8K | 54,613 | SEC↗ |
| STTK Shattuck Labs, Inc. | P Buy | 2022-04-22 | 2022-04-26 | 234 | $3.67 | $859 | 26,283 | SEC↗ |
| STTK Shattuck Labs, Inc. | P Buy | 2022-04-21 | 2022-04-26 | 26,049 | $3.69 | $96.1K | 26,049 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2022-01-04 | 2022-01-05 | 1,638 | — | $0 | 1,638 | SEC↗ |
| STTK Shattuck Labs, Inc. | A Award deriv | 2021-06-19 | 2021-06-22 | 3,434 | — | $0 | 3,434 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2021-06-10 | 2021-06-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2021-01-05 | 2021-01-06 | 832 | — | $0 | 832 | SEC↗ |
| STTK Shattuck Labs, Inc. | A Award deriv | 2020-12-22 | 2020-12-28 | 1,286 | — | $0 | 1,286 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award deriv | 2020-07-06 | 2020-07-08 | 81,000 | — | $0 | 81,000 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2020-06-09 | 2020-06-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2020-02-26 | 2020-02-28 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2020-01-03 | 2020-01-07 | 976 | — | $0 | 976 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2019-06-05 | 2019-06-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise deriv | 2019-03-04 | 2019-03-06 | 9,280 | — | $0 | 0 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise | 2019-03-04 | 2019-03-06 | 9,280 | $36.61 | $339.7K | 9,280 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2019-03-04 | 2019-03-06 | 9,280 | $103.65 | $961.9K | 0 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2019-02-28 | 2019-03-01 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise deriv | 2019-02-12 | 2019-02-13 | 3,728 | — | $0 | 0 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise deriv | 2019-02-12 | 2019-02-13 | 7,500 | — | $0 | 0 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise | 2019-02-12 | 2019-02-13 | 3,728 | $25.58 | $95.4K | 3,728 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise | 2019-02-12 | 2019-02-13 | 7,500 | $29.02 | $217.7K | 11,228 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2019-02-12 | 2019-02-13 | 11,228 | $90.07 | $1.01M | 0 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise deriv | 2019-02-11 | 2019-02-13 | 2,272 | — | $0 | 3,728 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2019-02-11 | 2019-02-13 | 2,272 | $90.03 | $204.5K | 0 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise | 2019-02-11 | 2019-02-13 | 2,272 | $25.58 | $58.1K | 2,272 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2019-01-22 | 2019-01-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2018-02-28 | 2018-03-05 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2017-02-16 | 2017-02-21 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2016-02-11 | 2016-02-12 | 6,000 | — | $0 | 6,000 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2015-02-19 | 2015-02-20 | 6,000 | — | $0 | 6,000 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2014-02-07 | 2014-02-11 | 9,280 | — | $0 | 9,280 | SEC↗ |